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In 1994, Wickner (1994) extended the prion concept to
Infectious, self-propagating protein aggregates (pri- explain the inheritance of two enigmatic non-Mendelian
ons) as well as structurally related amyloid fibrils have elements in the yeast Saccharomyces cerevisiae, called
traditionally been associated with neurodegenerative [URE3] and [PSI] (for reviews, see Serio and Lindquist,
diseases in mammals. However, recent work in fungi 1999; Wickner et al., 2000). Unlike in mammals, yeast
indicates that prions are not simply aberrations of pro- prions do not cause cell death, and can under certain
tein folding, but are in fact widespread, conserved, circumstances even enhance survival. The phenotypes
and in certain cases, apparently beneficial. Analysis associated with [URE3] or [PSI] elements are not partic-
of prion behavior in yeast has led to insights into the ularly exceptional: [URE3] alters nitrogen catabolite up-
mechanisms of prion appearance and propagation as take (Lacroute, 1971), while [PSI] increases the read-
well as the effect of prions on cellular physiology and through of certain stop codons during translation (Cox,
perhaps evolution. The prion-forming proteins of Sac- 1965). Indeed, traditional loss-of-function mutations in
charomyces cerevisiae are members of a larger class the chromosomally encoded nitrogen catabolism re-
of Gln/Asn-rich proteins that is abundantly repre- pressor Ure2p and the translation termination factor
sented in the genomes of higher eukaryotes, raising Sup35p mimic the [URE3] and [PSI] states, respec-
the prospect of genetically programmed prion-like be- tively. What make [URE3] and [PSI] so remarkable are
havior in other organisms. their epigenetic properties; they are inherited by all of
the meiotic progeny of diploid cells and can be transmit-
Origins of the Prion Hypothesis: Prions and Self- ted by transfer of cytoplasm from one cell to another
Replicating Protein Aggregates in Human Disease without the exchange of genetic material.
The concept of an infectious protein or prion was first To explain the unusual inheritance of [URE3] and
developed to explain the propagation of a set of related [PSI], Wickner proposed that these states result from
transmissible spongiform encephalopathies (TSEs; for the presence of self-propagating conformations or pri-
reviews, see Prusiner, 1998; Weissmann, 1999). The in- ons of the Ure2p and Sup35p proteins, respectively (see
fectious agent appeared to be composed largely (if not Figure 1). This model provides a mechanism for the
entirely) of a single endogenous protein called PrP. Re- nonnuclear inheritance and faithful propagation of the
markably, PrP can interconvert between two states, the [URE3] and [PSI] states; the prion forms can convert
normal form (termed PrPc) and its infectious variant free molecules of the affected protein and are them-
(PrPSc). PrPc has high -helical content, whereas PrPSc selves distributed along with the cytoplasm to all of the
adopts a  sheet-rich conformation and in some cases cell’s progeny. The prion model also explains why the
aggregates to form long polymers termed amyloid fi- phenotypes of [URE3] and [PSI] mimic the loss of func-
bers. These findings led to the “protein-only” hypothe- tion of Ure2p and Sup35p, as conversion inactivates the
sis, in which replication of the infectious agent results affected protein.
from the ability of aggregated PrPSc to bind and catalyze A number of elegant experiments have established
conversion of PrPc to PrPSc. that [URE3] and [PSI] result from self-propagating ag-
Despite concerns about the spread of Mad Cow dis- gregates of the Ure2p and Sup35p proteins. Ure2p or
ease (Collinge, 1999), TSEs remain extremely rare in Sup35p, which are ordinarily soluble, form protease-
humans. Prion-like amyloid protein aggregates are, resistant aggregates in cells that are [URE3] or [PSI]
however, intimately associated with a number of more (Masison and Wickner, 1995; Patino et al., 1996; Paush-
common nontransmissible human diseases (Dobson, kin et al., 1996; Edskes et al., 1999). The replication of
1999). These include a variety of sporadic conditions Ure2p and Sup35p aggregates has been recapitulated
such as the systemic amyloidoses, as well as relatively in vitro both in cell extracts and with pure protein (Glover
common neurodegenerative disorders such as Alzhei- et al., 1997; King et al., 1997; Paushkin et al., 1997;
mer’s disease and Parkinson’s disease. Protein aggre- Taylor et al., 1999; Thual et al., 1999; Schlumpberger et
gation also underlies the dominantly inherited polyglu- al., 2000; Serio et al., 2000). For example, upon dilution
tamine (polyGln) expansion disorders, which include from denaturant, Sup35p slowly forms amyloid fibers;
Huntington’s disease (HD) and Machado-Joseph dis- this conversion can be greatly accelerated by the addi-
ease (MJD; Perutz, 1999; Zoghbi and Orr, 2000). Each of tion of a small amount of preformed Sup35p fibers. This
these syndromes involves the aggregation of a different “seeding” effect lies at the heart of [PSI] prion replica-
tion; mutations in Sup35p that either enhance or inhibit
propagation of [PSI] in vivo cause a corresponding1 Correspondence: lxoshe@itsa.ucsf.edu
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Figure 1. Prion Model of [PSI]
Sup35p is a modular protein (top) consisting
of an amino-terminal Gln/Asn-rich prion do-
main (N), a highly charged middle domain (M),
and a conserved carboxy-terminal translation
termination domain (EF). In [psi] yeast,
Sup35p is soluble and functional, leading to
robust translation termination at stop co-
dons. In [PSI] yeast, Sup35p aggregates into
a prion form via its N domain. Recruitment of
newly made Sup35p allows propagation of
the [PSI] prion, while depletion of soluble
Sup35p promotes the suppression of certain
stop codons, leading to a selectable pheno-
type if an appropriate marker is used.
increase or decrease in the rate of Sup35p polymeriza- typically varies from one prion to another; for example,
while deletion of HSP104 cures all known yeast prions,tion in vitro (Glover et al., 1997; DePace et al., 1998;
overexpression seems to cure only [PSI]. Likewise,Kochneva-Pervukhova et al., 1998; Liu and Lindquist,
overexpression of the Hsp40 protein Ydj1p efficiently1999). Finally, mutant Sup35p that cannot seed the poly-
cures [URE3] (Moriyama et al., 2000) but not [PSI]. Themerization of wild-type protein in vitro also fails to con-
stable maintenance of prions may thus involve a balancevert cells to [PSI] when overexpressed or introduced
between specific chaperone activities and the intrinsicinto yeast by liposome fusion (Sparrer et al., 2000).
tendency of prion aggregates to grow and divide.[URE3] and [PSI] are examples of a broader phenom-
Recent studies have begun to address how Hsp104penon of glutamine- and asparagine-rich (Gln/Asn-rich)
may function to enhance prion propagation. Hsp104pprotein aggregation of the kind implicated in human
directly interacts with nonpolymerized Sup35p in vitropolyGln expansion disorders such as HD. The prion
(Schirmer and Lindquist, 1997), suggesting that excessproperties of Ure2p and Sup35p depend on Gln/Asn-
Hsp104p could cure [PSI] either by sequesteringrich domains at the amino termini of these proteins (Ter-
Sup35p or folding it into a state that is not susceptibleAvanesyan et al., 1993; Masison and Wickner, 1995;
to prion conversion. The requirement for endogenousPaushkin et al., 1996; DePace et al., 1998; Parham et
levels of Hsp104p for the propagation of all yeast prionsal., 2001). These prion domains are otherwise dispens-
could result from the ability of this chaperone to break upable for the normal functions of Ure2p and Sup35p and
large protein aggregates (Glover and Lindquist, 1998),are modular, conferring the ability to aggregate when
thereby generating new prion seeds that are partitionedtransferred to other proteins (Patino et al., 1996; Edskes
among dividing cells (Kushnirov and Ter-Avanesyan,et al., 1999; Li and Lindquist, 2000). The structural basis
1998). Consistent with this view, Hsp104p is not requiredof Gln/Asn-rich aggregation is thought to involve forma-
for the de novo Sup35p aggregation (Osherovich andtion of “polar zippers,” in which the  sheets are stabi-
Weissman, 2001; M. Tuite, personal communication),lized by a network of hydrogen bonds involving the glu-
while depletion of Hsp104p activity in [PSI] cells de-tamine and asparagine side chains (Perutz et al., 1994).
creases the number of Sup35p aggregates but increasesHowever, not every Gln/Asn-rich aggregate is a prion;
their size (Wegrzyn et al., 2001). Additionally, the curingin order to replicate and distribute itself among dividing
of prions by growth in the presence of guanidine hydro-cells, an aggregate may require additional structural fea-
chloride, a small molecule that was recently shown totures or interactions with other cellular factors.
inhibit Hsp104p in vivo (Ferreira et al., 2001; Jung and
Masison, 2001), results from the inability of the prion
Chaperones Modulate Prion Inheritance In Vivo seed to replicate. Efficient guanidine-mediated curing
Although many Gln/Asn-rich proteins such as Sup35p of [PSI] requires roughly seven cell divisions, regard-
and Ure2p have an intrinsic tendency to form self-repli- less of how quickly these divisions occur; this finding
cating amyloid aggregates in vitro, the propagation of has allowed Eaglestone et al. (2000) to estimate that a
yeast prions in vivo depends critically on a variety of typical [PSI] cell has approximately 60 independent
chaperone proteins (Table 1). Certain chaperones that prion seeds.
play a general role in ensuring proper protein folding, Another example of the interplay of chaperone activi-
including members of the Hsp70 and Hsp40 families, ties on prions comes from the opposing effects of differ-
inhibit prion formation and replication while other Hsp70 ent Hsp70 proteins on [PSI] (see Table 1). One family
and Hsp40 chaperones actually promote prion propaga- of these ubiquitous cytosolic chaperones, the SSA pro-
tion. Hsp104p, a chaperone that enhances thermotoler- teins, appears to promote the aggregation of Sup35p;
ance by disaggregating heat-denatured proteins (Lind- overexpression of SSA proteins increases the extent of
quist et al., 1995) does both; either an excess or a Sup35p aggregation and antagonizes the curing of
deficiency of Hsp104p results in the loss of [PSI] (Cher- [PSI] by HSP104 overexpression (Newnam et al., 1999),
whereas depletion of SSA activity promotes the loss ofnoff et al., 1995). The action of a particular chaperone
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Table 1. Summary of the Relationships between Chaperones and Yeast Prions
Family Yeast Protein Prion Effect Citation
HSP100 Hsp104p [PSI]/[ETA] : cures Chernoff et al., 1995
Zhou et al., 1999
″ ″ ″ ″ ↑: cures ″ ″
″ ″ [PSIps] : cures Kushnirov et al., 2000b
″ ″ ″ ″ ↑: no effect ″ ″
″ ″ [PSICA]/ : cures Santoso et al., 2000
[CHICA]
″ ″ ″ ″ ↑: cures ″ ″
″ ″ [PIN]/[RNQ] : cures Derkatch et al., 1997
″ ″ ″ ″ ↑: no effect ″ ″
″ ″ [URE3] : cures Moriyama et al., 2000
″ ″ ″ ″ ↑: no effect ″ ″
″ ″ [NU] : cures Osherovich and Weissman,
2001
″ ″ ″ ″ ↑: no effect L.Z.O. and J.S.W.,
unpublished data
HSP70 Ssa1p/Ssa2p [PSI] Mutant alleles cure* Jung et al., 2000
″ ″ ″ ″ ↑: antagonizes curing by Hsp104p Newnam et al., 1999
overexpression; enhances
prion phenotype
″ ″ [PSIps] ↑: cures (enhanced by Ydj1p Kushnirov et al., 2000b
cooverexpression)
″ ″ [PIN]/[RNQ] Interacts with the prion form Sondheimer et al., 2001
of Rnq1p
Ssb1p/Ssb2p [PSI] : antagonizes curing by Hps104p Chernoff et al., 1999
overexpression; increases rate
of prion appearance
″ ″ ″ ″ ↑: cures or enhances curing by Chernoff et al., 1999
HSP104 overexpression Chacinska et al., 2001
″ ″ [PSIps] ↑: cures Kushnirov et al., 2000b
HSP40 Ydj1p [PSIps] ↑: cures (enhanced by SSA ″ ″
cooverexpression)
″ ″ [URE3] ↑: cures Moriyama et al., 2000
Sis1p [PIN]/[RNQ] Deletion of the C-terminal domain Sondheimer et al., 2001
cures; other mutations affect
prion aggregate morphology;
interacts with prion form
of protein
Small HSPs Hsp26 [PSI] ↑: no effect M. Tuite, personal
communication
″ ″ ″ ″ : no effect Eaglestone et al., 1999
 indicates deletion, ↑ indicates overexpression. Prions are listed with their closely related variants or alternative names. [PSIps] is a prion
form of the Pichia methanolica Sup35p, while [PSICA]/[CHICA] is that of Candida albicans.
* When both SSA1 and SSA2 are deleted, the homologous SSA3 and SSA4 genes are induced, thus allowing [PSI] propagation. Jung et al.
(2000) obtained an allele of SSA1 that, in combination with the SSA2 deletion, does not induce SSA3/SSA4 and results in the loss of [PSI].
[PSI] (Jung et al., 2000). Conversely, another family of lost, as mutational studies have found that even single
point mutations within the Sup35p prion domain areHsp70 proteins, encoded by SSB1 and SSB2, antago-
nizes Sup35p aggregation; overexpression of SSB pro- sufficient to dramatically inhibit [PSI] propagation in
vivo (Doel et al., 1994; DePace et al., 1998). However,teins enhances curing of [PSI] while deletion has the
opposite effect (Chernoff et al., 1999; Chacinska et al., analysis of the amino-terminal domains of Sup35p from
a variety of budding yeast species separated by many2001). As SSB chaperones are thought to act upon na-
scent proteins during translation, it is possible that the millions of years of evolution revealed the conservation
of the fundamental properties of these proteins (Cher-conversion of Sup35p to a prion state may occur during
the protein’s synthesis, before it has adopted a final noff et al., 2000; Kushnirov et al., 2000a; Santoso et al.,
stable conformation. 2000; Zadorskii et al., 2000). While the specific se-
quences of these prion domains are rather divergent,
the amino-terminal portions of Sup35p from all of theConservation and Utility of [PSI]
examined species share a high Gln/Asn content as wellSeveral observations suggest that [PSI] prions are con-
as a set of imperfect oligopeptide repeats, featuresserved and may even serve important biological func-
shown by mutational analysis to be critical for priontions. [PSI] is found in many laboratory strains, even
propagation.in the absence of specific selection for stop codon read-
When transplanted into S. cerevisiae, the Gln/Asn-richthrough. If the [PSI] state provided no benefit, one
might expect that the ability to form it would rapidly be domains of Sup35p from other yeasts could reversibly
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aggregate into [PSI]-like states, the formation and
propagation of which typically displayed a high degree
of specificity for proteins of their own kind. For example,
in a strain expressing the amino-terminal domains of
Sup35p from both S. cerevisiae and Candida albicans,
each protein formed a prion that propagated indepen-
dently of the state of the other protein. This specificity
resembles the “species barrier” that ordinarily prevents
interaction between PrP prions from different animals.
The Sup35p prion domains from different yeasts have
allowed several groups to study the basis and limita-
tions of prion specificity in vivo and in vitro (Chien and
Weissman, 2001; King, 2001; Nakayashiki et al., 2001).
Recently, Nakayashiki et al. (2001) have reported a
[PSI]-like phenomenon with an associated translation
termination defect in Kluyveromyces lactis that results
Figure 2. Gln/Asn-Rich Tracts Are Abundant in Certain Eukaryoticfrom prion formation by the homolog of Sup35p. Thus,
Proteomes
it seems that in addition to the prion-forming Gln/Asn-
(Michelitsch and Weissman, 2000). The complete genomic se-rich domain, the cellular machinery needed for [PSI]
quences of three eukaryotes as well as of 20 bacteria and archae
propagation is conserved in other yeasts. were searched for Gln/Asn-rich tracts, defined as regions of open
Why are the prion properties of Sup35p conserved? reading frames (ORFs) with 30 or more Gln and Asn residues per
80-residue window. The frequency of such sequences in the eukary-Perhaps natural selection favors yeasts that can switch
otes is much greater than expected if amino acid composition werethe activity of this protein on and off in an epigenetically
due to chance. Interestingly, the recently sequenced human genomeheritable manner. Two groups have examined whether
has a lower abundance (0.3%) of predicted Gln/Asn-rich tracts[PSI] can confer a selective advantage under condi-
than other metazoans (M. Michelitsch and J.S.W., unpublished
tions that resemble those encountered by yeast in the data).
wild. Eaglestone et al. (1999) found that [PSI] strains
exhibited an elevated tolerance to heat stress and etha-
nol as a result of their defective translation termination. (Santoso et al., 2000; Sondheimer and Lindquist, 2000).
True and Lindquist (2000) compared [PSI] isolates of As it was difficult to anticipate the prion-associated phe-
a number of different genetic backgrounds with their notypes for these proteins, many of which were nones-
prion-free (or [psi]) derivatives, and found that under a sential or poorly characterized, both we and Sondheimer
number of growth conditions certain yeast strains grew and Lindquist made use of the easily assayed translation
better if they were [PSI], while many other conditions termination phenotype of [PSI]. To test for prion forma-
favored [psi] cells. These observations led to the inter- tion by candidate sequences, these were swapped into
esting proposal that [PSI] may act as an “evolutionary the SUP35 gene to replace the endogenous prion do-
capacitor” (Rutherford and Lindquist, 1998), which main; the resulting chimeric proteins were then tested
allows previously neutral genetic variation to convert to for the ability to form a [PSI]-like state after transient
a nonneutral state, thereby facilitating the evolution of overexpression of the putative prion protein in question.
new traits (True and Lindquist, 2000). De novo appear- Using this “artificial prion” method, two previously
ance of yeast prions can be stimulated by prolonged uncharacterized proteins (New1p and Rnq1p) were
incubation at low temperature (Chernoff et al., 1995; found to contain prion domains. A fusion of the first 153
Derkatch et al., 2000; Y.O. Chernoff, personal communi- residues of New1p and the translation domain of Sup35p
cation), while the reversion of [PSI] to [psi] can be could interconvert between two states, termed [nu] and
triggered by chemical agents such as guanidine (Tuite [NU], which respectively resulted from soluble and ag-
et al., 1981). Thus, although the ability to form and propa- gregated forms of the chimeric protein. Similarly, a
gate the [PSI] prion must have resulted from natural Sup35p fusion with the carboxy-terminal portion of
selection, the environmental responsiveness and epige- Rnq1p could reversibly form an aggregated state termed
netic properties of the prion itself are reminiscent of [RPS]. The full-length Rnq1p also appeared to form a
Lamarckian “inheritance of acquired characteristics” genuine endogenous prion in a number of “wild-type”
(Chernoff, 2001). yeast strains, as it was found in a high molecular weight
complex that could be permanently disrupted by treat-
ment of the cells with guanidine. However, no obviousPrediction and Identification of Novel Prions
The discovery of conserved and perhaps adaptive prop- phenotype associated with the Rnq1p prion was initially
evident.erties of [PSI] raises the question of whether prion
forms of proteins other than Sup35p and Ure2p exist. A different line of experimentation had earlier uncov-
ered a prion-like epigenetic element with surprisingA surprisingly large number of Gln/Asn-rich sequences
reminiscent of the prion domains of Ure2p and Sup35p properties. Derkatch et al. (1997) described a cryptic
epigenetic state called [PIN] (PSI inducibility) that influ-can be predicted from eukaryotic genomes including
those of S. cerevisiae, C. elegans, and D. melanogaster enced the cell’s susceptibility to the de novo induction
of [PSI]; only strains that possessed the [PIN] trait(Figure 2; Michelitsch and Weissman, 2000). Initial ef-
forts to test prion formation by these proteins concen- could readily convert to [PSI] upon overexpression of
Sup35p. [PIN] had all the hallmarks of a prion includingtrated on yeast because of the ease of genetic analysis
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cytoplasmic inheritance, reversible curing, and depen- aggregates (Figure 3A). For example, there is evidence
for a low level of “cross-seeding” between certaindence on cellular chaperones. However, propagation of
[PIN] did not require Sup35p and was independent of Sup35p prions (Nakayashiki et al., 2001). A related model
(Figure 3B) postulates that the presence of prions in-[PSI], suggesting that [PIN] was a naturally occurring
prion form of some other protein. This conclusion was duces or activates an enzymatic activity that itself pro-
motes the aggregation of other proteins; for example,confirmed by the subsequent identification of Rnq1p as
the protein behind [PIN] (Derkatch et al., 2001). one type of prion could recruit and concentrate chaper-
ones, thereby providing a surface for the assembly of
other prions. In both of these models, the aggregate-Prions Affect the Aggregation of Other Proteins
promoting prions have a stimulatory effect on a processSurprisingly, Rnq1p is only one of a large number of
that ordinarily is unfavorable.proteins that, when aggregated, can render a cell sus-
An alternative model proposes that aggregation-ceptible to [PSI] induction (Derkatch et al., 2001; Osher-
prone proteins are prevented from establishing stableovich and Weissman, 2001). To identify the protein(s)
aggregates by the action of an inhibitory factor that canresponsible for the [PIN] phenomenon, Derkatch et al.
be inactivated by the presence of prions (Figure 3C).(2001) reasoned that overexpression of the appropriate
Consistent with this model, de novo aggregation ap-prion-forming protein might spontaneously induce a
pears to be inhibited in prion-free cells; for example,[PIN]-like state. A screen for [PSI]-promoting high-
Sup35p spontaneously forms aggregates in vitro at verycopy plasmids yielded NEW1, URE2, and nine other
low concentrations, but even strong overexpression ofgenes, all of which encoded proteins with Gln/Asn-rich
Sup35p in [pin] cells causes neither [PSI] inductiondomains. Concurrently, a candidate gene approach
nor the appearance of detectable Sup35p aggregates.(Osherovich and Weissman, 2001) demonstrated that
Moreover, extracts prepared from yeast strains lackingoverexpression of the Gln/Asn-rich domains of New1p
Hsp104p, and thus any endogenous prions such asand Rnq1p obviated the requirement for [PIN] in the
[PIN], inhibit the spontaneous aggregation of polyGln-process of [PSI] induction. In each case, it was specifi-
expanded huntingtin protein to a greater degree than docally the aggregated form of the protein in question that
wild-type extracts (Cao et al., 2001). A similar inhibitorymade cells susceptible to the induction of [PSI]. For
effect of extracts on Sup35p polymerization in vitro hasexample, the prion form of New1p, [NU], promoted
recently been observed by Uptain et al. (2001). However,[PSI] induction at an efficiency comparable to that of
genetic screens for mutations that lead to phenotypicthe endogenous [PIN] prion.
emulation of [PIN] by inactivating inhibitors of prionThis epigenetic regulation of protein aggregation ex-
formation have thus far been unsuccessful (Derkatch ettends beyond [PSI] induction and even beyond prions.
al., 2001). One potential target of [PIN] elements whichThe prion-promoting relationship between aggregation-
might be difficult to identify genetically due to its essen-prone proteins is reciprocal; the presence of Sup35p
tial role in protein metabolism is the ubiquitin-protea-aggregates (i.e., [PSI]) allows other prion-forming pro-
some machinery. In mammalian cells, the proteasometeins such as Ure2p and Rnq1p to themselves form
can be saturated by Gln/Asn-rich aggregates (Bence etaggregates (Derkatch et al., 2001). Furthermore, the ag-
al., 2001); this could prevent the degradation of aggrega-gregation of polyGln-expanded MJD protein in yeast
tion-prone proteins, leading to their accumulation andwas greatly enhanced by the presence of aggregation-
eventual conversion to prions or other aggregates.promoting prions such as [PIN] and [NU] (Osherovich
and Weissman, 2001), suggesting the possible rele-
vance of prion-facilitated aggregation to human disease. Normal Protein Activity by Prions
Prions of mammals and yeast have traditionally beenThe screen for prion-promoting proteins developed
by Derkatch et al. (2001) also provides a potential thought of as aberrant protein states that interfere with
protein function or cause toxicity. However, recent workmethod for identifying novel prion-like elements. The
genes identified in this screen include a number of inter- on the filamentous fungus Podospora anserina has un-
expectedly uncovered a role for prions in the “normal”esting candidates such as a casein kinase (Yck1p), an
Sm-like protein (Lsm4p), and a well-characterized chro- biology of this organsim.
Many filamentous fungi, including P. anserina, growmatin remodeling factor (Swi1p). The latter is part of a
larger protein complex involved in global transcriptional as haploid syncitial networks termed mycelia. When two
mycelia encounter each other, they can fuse and growactivation (reviewed by Sudarsanam and Winston, 2000)
that includes Swi3p, Snf2p, Snf5p, Snf6p, and Snf11p, as a single network called a heterokaryon, with nuclei
and cytoplasm from both parent colonies. However, sta-all which contain Gln/Asn-rich tracts. While there is no
evidence that components of the Swi/Snf complex form ble heterokaryon propagation occurs only if both part-
ners have identical alleles at a number of genetic “heter-prions, it is possible that the Gln/Asn-rich sequences in
these proteins stabilize interactions between them in a okaryon incompatibility” loci (Saupe et al., 2000). There
are nine such het loci in P. anserina. One of these, themanner that resembles the  sheet structure of amy-
loids. S locus, has two principle allelic variants that are de-
noted in upper and lower case and encode proteins thatHow could prions promote the appearance of other
protein aggregates? Any model must account for the differ from one another by thirteen residues. When a
het-S strain fuses with an incompatible het-s strain, thefact that these prions act through a dominant, gain-of-
function mechanism, rather than because of depletion resulting heterokaryon rapidly dies and becomes cut off
from the rest of the mycelium.of their normal protein activity. One possibility is that
prions can directly seed the growth of other prions or The prion connection emerged from the discovery that
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Figure 3. Three Hypothetical Models for
Prion-Facilitated Initiation of Aggregation
(A) Cross-seeding. In this model, multiple ag-
gregation-prone proteins can directly interact
with one another. For example, the prion form
of one protein (purple) seeds the aggregation
of another (blue).
(B) Stimulation of aggregation. Prions (purple)
activate or induce the expression of a protein
or complex (yellow), which then promotes the
conversion of another protein (blue) to an ag-
gregated form.
(C) Inhibition of antiaggregation. An aggrega-
tion-prone protein (blue) is prevented from
aggregating or is disaggregated by the action
of an inhibitory protein or complex (pink).
However, prions (purple) can interact with
and inactivate this antiaggregation factor,
perhaps by acting as competitive inhibitors.
The blue protein is then free to aggregate.
genetically identical het-s strains can exist in two states, have a tendency to aggregate in vitro, it seems likely that
a functional form called [Het-s] and an inactive variant at least some of them might support prion propagation
called [Het-s*] (see Coustou et al., 1997). The het-s gene when expressed in yeast. However, Gln/Asn content
is the same in both [Het-s] and [Het-s*] strains, but when should not be the sole criterion used to search for novel
the two strains form a heterokaryon, the [Het-s] state is prions, as neither PrP nor Het-s is particularly Gln/Asn
dominant; furthermore, the [Het-s] form spreads rapidly rich.
through the recipient [Het-s*] mycelium and can in cer- Even if prion-forming proteins from other organisms
tain cases be passed down to all of the haploid progeny are identified using the yeast system, the real challenge
of a sexual cross. Propagation of the [Het-s] state re- would be to observe prions within their natural hosts.
quires a 25-residue N-terminal sequence of the HET-s The best candidate genes could be transiently overex-
protein (Coustou et al., 1999). Finally, the HET-s protein pressed in worms or flies and assayed for subsequent
is aggregated and resistant to proteolysis in cellular self-propagating aggregation. However, it is difficult to
extracts from [Het-s] strains, and forms amyloid fibrils predict what effect any such prion states would have
in vitro (Dos Reis et al., 2001). These data argue that on the cell or the organism, especially if the function of
the [Het-s] state results from prion formation by the the protein in question is unknown. Prions could inacti-
HET-s protein. Rather than diminishing the activity of vate the affected protein as in [PSI], or may have domi-
HET-s protein, the prion form here appears to be re- nant effects akin to the aggregation-promoting effects
quired for its normal physiological function. of [PIN] and [NU]. For example, prions might enhance
the aggregation and deleterious effects of polyGln-
expanded proteins in worms and flies, as they do inAre There Prions in Other Organisms?
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